Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (61-70 of 363) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|May 1, 1994
Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study GroupC E Swanson, B Tindall, D A Cooper
HIV Medicine|December 12, 2001
HIV-associated lipodystrophyP W Mallon, D A Cooper, A Carr
Acta Haematologica|January 1, 1982
Biosynthesis of immunoglobulin in human immunoproliferative diseases. II. Comparison of tumour cell mass in multiple myeloma measured by synthetic rate studies with that calculated from clinical staging systemsD A Cooper, A C Miller, R Penny
Progress in Clinical Cancer|January 1, 1970
Resection and survival in bronchogenic carcinomaK R Boucot, D A Cooper, W Weiss
AIDS (London, England)|July 29, 1998
Clinical trials in AsiaP Phanuphak, D A Cooper, J M Lange
JAMA|June 28, 1971
The Philadelphia pulmonary neoplasm research project. Survival factors in bronchogenic carcinomaW Weiss, K R Boucot, D A Cooper
The Medical Clinics of North America|May 1, 1970
The Philadelphia Pulmonary Neoplasm Research ProjectK R Boucot, D A Cooper, W Weiss
The Journal of Infectious Diseases|May 1, 1991
The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier stateN J Bodsworth, D A Cooper, B Donovan
The Medical Journal of Australia|March 4, 1996
Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIVS Crowe, D A Cooper, D E Chambers
The Journal of Infectious Diseases|June 1, 1987
Antibody response to human immunodeficiency virus after primary infectionD A Cooper, A A Imrie, R Penny
Pageof 37

Showing results (61-70 of 363) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|May 1, 1994
Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study GroupC E Swanson, B Tindall, D A Cooper
HIV Medicine|December 12, 2001
HIV-associated lipodystrophyP W Mallon, D A Cooper, A Carr
Acta Haematologica|January 1, 1982
Biosynthesis of immunoglobulin in human immunoproliferative diseases. II. Comparison of tumour cell mass in multiple myeloma measured by synthetic rate studies with that calculated from clinical staging systemsD A Cooper, A C Miller, R Penny
Progress in Clinical Cancer|January 1, 1970
Resection and survival in bronchogenic carcinomaK R Boucot, D A Cooper, W Weiss
AIDS (London, England)|July 29, 1998
Clinical trials in AsiaP Phanuphak, D A Cooper, J M Lange
JAMA|June 28, 1971
The Philadelphia pulmonary neoplasm research project. Survival factors in bronchogenic carcinomaW Weiss, K R Boucot, D A Cooper
The Medical Clinics of North America|May 1, 1970
The Philadelphia Pulmonary Neoplasm Research ProjectK R Boucot, D A Cooper, W Weiss
The Journal of Infectious Diseases|May 1, 1991
The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier stateN J Bodsworth, D A Cooper, B Donovan
The Medical Journal of Australia|March 4, 1996
Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIVS Crowe, D A Cooper, D E Chambers
The Journal of Infectious Diseases|June 1, 1987
Antibody response to human immunodeficiency virus after primary infectionD A Cooper, A A Imrie, R Penny
Pageof 37